Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Finkelmeier

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
JHEP Reports : Innovation in Hepatology|February 18, 2026
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinomaJan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.
Journal of Cancer Research and Clinical Oncology|July 21, 2024
Small duct and large duct type intrahepatic cholangiocarcinoma reveal distinct patterns of immune signaturesSimon Bernatz, Falko Schulze, Julia Bein, et al.
Journal of Clinical Microbiology|May 3, 2019
Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 ChimerasKai-Henrik Peiffer, Lisa Kuhnhenn, Evelyn Stelzl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2017
Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal TransitionAhmed Atef Ibrahim, Christian Schmithals, Erik Kowarz, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACEMaximilian N Kinzler, Katrin Bankov, Julia Bein, et al.
JHEP Reports : Innovation in Hepatology|June 12, 2023
Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 yearsChristiana Graf, Lara Fuhrmann, Thomas Lutz, et al.
Annals of Hematology|September 25, 2020
Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapyOlivier Ballo, Eva-Maria Kreisel, Fagr Eladly, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|September 2, 2024
A novel ultrasound-based algorithm for the detection of pancreatic stents placed for prophylaxis of post-ERCP pancreatitis: a prospective trialFlorian Alexander Michael, Clara Feldmann, Hans-Peter Erasmus, et al.
Gut|January 27, 2023
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockadeClaire Conche, Fabian Finkelmeier, Marina Pešić, et al.
Anticancer Research|March 28, 2023
Identification of Atezolizumab Plus Bevacizumab Prognostic Index <i>via</i> Recursive Partitioning Analysis in HCC: The ABE IndexMara Persano, Margherita Rimini, Toshifumi Tada, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
JHEP Reports : Innovation in Hepatology|February 18, 2026
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinomaJan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.
Journal of Cancer Research and Clinical Oncology|July 21, 2024
Small duct and large duct type intrahepatic cholangiocarcinoma reveal distinct patterns of immune signaturesSimon Bernatz, Falko Schulze, Julia Bein, et al.
Journal of Clinical Microbiology|May 3, 2019
Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 ChimerasKai-Henrik Peiffer, Lisa Kuhnhenn, Evelyn Stelzl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2017
Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal TransitionAhmed Atef Ibrahim, Christian Schmithals, Erik Kowarz, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACEMaximilian N Kinzler, Katrin Bankov, Julia Bein, et al.
JHEP Reports : Innovation in Hepatology|June 12, 2023
Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 yearsChristiana Graf, Lara Fuhrmann, Thomas Lutz, et al.
Annals of Hematology|September 25, 2020
Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapyOlivier Ballo, Eva-Maria Kreisel, Fagr Eladly, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|September 2, 2024
A novel ultrasound-based algorithm for the detection of pancreatic stents placed for prophylaxis of post-ERCP pancreatitis: a prospective trialFlorian Alexander Michael, Clara Feldmann, Hans-Peter Erasmus, et al.
Gut|January 27, 2023
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockadeClaire Conche, Fabian Finkelmeier, Marina Pešić, et al.
Anticancer Research|March 28, 2023
Identification of Atezolizumab Plus Bevacizumab Prognostic Index <i>via</i> Recursive Partitioning Analysis in HCC: The ABE IndexMara Persano, Margherita Rimini, Toshifumi Tada, et al.
Pageof 13